{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:58:10Z","timestamp":1793973490278,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T00:00:00Z","timestamp":1355788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1245\/s10434-012-2803-7","type":"journal-article","created":{"date-parts":[[2012,12,17]],"date-time":"2012-12-17T21:47:19Z","timestamp":1355780839000},"page":"1482-1490","source":"Crossref","is-referenced-by-count":40,"title":["Early Viral Suppression Predicts Good Postoperative Survivals in Patients with Hepatocellular Carcinoma with a High Baseline HBV-DNA Load"],"prefix":"10.1245","volume":"20","author":[{"given":"Gang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-ya","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-yuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Yee","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,18]]},"reference":[{"key":"2803_CR1","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557\u201376.","journal-title":"Gastroenterology."},{"key":"2803_CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65\u201373.","journal-title":"JAMA."},{"key":"2803_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1200\/JCO.2007.13.2043","volume":"26","author":"HL Chan","year":"2008","unstructured":"Chan HL, Tse CH, Mo F, et al. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. J Clin Oncol. 2008;26:177\u201382.","journal-title":"J Clin Oncol."},{"key":"2803_CR4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020\u20132.","journal-title":"Hepatology."},{"key":"2803_CR5","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O","volume":"89","author":"RT Poon","year":"2000","unstructured":"Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500\u20137.","journal-title":"Cancer."},{"key":"2803_CR6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000658-200007000-00003","volume":"232","author":"R Tung-Ping Poon","year":"2000","unstructured":"Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10\u201324.","journal-title":"Ann Surg."},{"key":"2803_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.amjsurg.2006.06.051","volume":"194","author":"S Ibrahim","year":"2007","unstructured":"Ibrahim S, Roychowdhury A, Hean TK. Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Am J Surg. 2007;194:17\u201322.","journal-title":"Am J Surg."},{"key":"2803_CR8","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1572-0241.2008.01872.x","volume":"103","author":"IF Hung","year":"2008","unstructured":"Hung IF, Poon RT, Lai CL, Fung J, Fan ST, Yuen MF. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection. Am J Gastroenterol. 2008;103:1663\u201373.","journal-title":"Am J Gastroenterol."},{"key":"2803_CR9","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1440-1746.2006.04707.x","volume":"22","author":"T Kuzuya","year":"2007","unstructured":"Kuzuya T, Katano Y, Kumada T, et al. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22:1929\u201335.","journal-title":"J Gastroenterol Hepatol."},{"key":"2803_CR10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00535-009-0093-z","volume":"44","author":"M Chuma","year":"2009","unstructured":"Chuma M, Hige S, Kamiyama T, et al. The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma. J Gastroenterol. 2009;44:991\u20139.","journal-title":"J Gastroenterol."},{"key":"2803_CR11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1245\/s10434-009-0694-z","volume":"17","author":"N Li","year":"2010","unstructured":"Li N, Lai EC, Shi J, et al. A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection. Ann Surg Oncol. 2010;17:179\u201385.","journal-title":"Ann Surg Oncol."},{"key":"2803_CR12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1365-2036.2011.04634.x","volume":"33","author":"JS Wong","year":"2011","unstructured":"Wong JS, Wong GL, Tsoi KK, et al. Meta-analysis: the efficacy of anti-viral therapy in prevention of recurrence after curative treatment of chronic hepatitis B-related hepatocellular carcinoma. Aliment Pharmacol Ther. 2011;33:1104\u201312.","journal-title":"Aliment Pharmacol Ther."},{"key":"2803_CR13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421\u201330.","journal-title":"J Hepatol."},{"key":"2803_CR14","first-page":"150","volume":"13","author":"AS Lok","year":"2004","unstructured":"Lok AS, McMahon BJ. [AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]. Rom J Gastroenterol. 2004;13:150\u20134.","journal-title":"Rom J Gastroenterol."},{"key":"2803_CR15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","volume":"45","author":"AS Lok","year":"2007","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507\u201339.","journal-title":"Hepatology."},{"key":"2803_CR16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.gastro.2007.11.036","volume":"134","author":"JM Pawlotsky","year":"2008","unstructured":"Pawlotsky JM, Dusheiko G, Hatzakis A, et al. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. Gastroenterology. 2008;134:405\u201315.","journal-title":"Gastroenterology."},{"key":"2803_CR17","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1002\/cncr.10557","volume":"94","author":"K Ohkubo","year":"2002","unstructured":"Ohkubo K, Kato Y, Ichikawa T, et al. Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma. Cancer. 2002;94:2663\u20138.","journal-title":"Cancer."},{"key":"2803_CR18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jhep.2007.06.019","volume":"47","author":"HC Sun","year":"2007","unstructured":"Sun HC, Zhang W, Qin LX, et al. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol. 2007;47:684\u201390.","journal-title":"J Hepatol."},{"key":"2803_CR19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1478-3231.2007.01625.x","volume":"28","author":"BK Kim","year":"2008","unstructured":"Kim BK, Park JY, Kim do Y, et al. Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection. Liver Int. 2008;28:393\u2013401.","journal-title":"Liver Int."},{"key":"2803_CR20","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1440-1746.2010.06416.x","volume":"25","author":"HJ An","year":"2010","unstructured":"An HJ, Jang JW, Bae SH, et al. Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2010;25:1876\u201382.","journal-title":"J Gastroenterol Hepatol."},{"key":"2803_CR21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1872-034X.2007.00013.x","volume":"37","author":"S Kubo","year":"2007","unstructured":"Kubo S, Tanaka H, Takemura S, et al. Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus. Hepatol Res. 2007;37:94\u2013100.","journal-title":"Hepatol Res."},{"key":"2803_CR22","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/hep.21939","volume":"46","author":"MF Yuen","year":"2007","unstructured":"Yuen MF, Fong DY, Wong DK, Yuen JC, Fung J, Lai CL. Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response. Hepatology. 2007;46:1695\u2013703.","journal-title":"Hepatology."},{"key":"2803_CR23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1365-2036.2007.03272.x","volume":"25","author":"HL Chan","year":"2007","unstructured":"Chan HL, Wong VW, Tse CH, et al. Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B. Aliment Pharmacol Ther. 2007;25:891\u20138.","journal-title":"Aliment Pharmacol Ther."},{"key":"2803_CR24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","volume":"136","author":"YF Liaw","year":"2009","unstructured":"Liaw YF, Gane E, Leung N, et al. 2-year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology. 2009;136:486\u201395.","journal-title":"Gastroenterology."},{"key":"2803_CR25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2003.08.010","volume":"60","author":"M Colombo","year":"2003","unstructured":"Colombo M, Sangiovanni A. Etiology, natural history and treatment of hepatocellular carcinoma. Antiviral Res. 2003;60:145\u201350.","journal-title":"Antiviral Res."},{"key":"2803_CR26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3748\/wjg.v13.i1.74","volume":"13","author":"J Lupberger","year":"2007","unstructured":"Lupberger J, Hildt E. Hepatitis B virus\u2013induced oncogenesis. World J Gastroenterol. 2007;13:74\u201381.","journal-title":"World J Gastroenterol."},{"key":"2803_CR27","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1053\/j.gastro.2010.01.042","volume":"138","author":"JD Chen","year":"2010","unstructured":"Chen JD, Yang HI, Iloeje UH, et al. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology. 2010;138:1747\u201354.","journal-title":"Gastroenterology."},{"key":"2803_CR28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","volume":"347","author":"HI Yang","year":"2002","unstructured":"Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347:168\u201374.","journal-title":"N Engl J Med."},{"key":"2803_CR29","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0092-8674(89)90770-8","volume":"59","author":"FV Chisari","year":"1989","unstructured":"Chisari FV, Klopchin K, Moriyama T, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 1989;59:1145\u201356.","journal-title":"Cell."},{"key":"2803_CR30","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO;2-V","volume":"88","author":"S Kubo","year":"2000","unstructured":"Kubo S, Hirohashi K, Tanaka H, et al. Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma. Cancer. 2000;88:1016\u201324.","journal-title":"Cancer."},{"key":"2803_CR31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000050093","volume":"18","author":"S Kubo","year":"2001","unstructured":"Kubo S, Hirohashi K, Tanaka H, et al. Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma. Dig Surg. 2001;18:26\u201333.","journal-title":"Dig Surg."},{"key":"2803_CR32","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","volume":"359","author":"Y Hoshida","year":"2008","unstructured":"Hoshida Y, Villanueva A, Kobayashi M, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med. 2008;359:1995\u20132004.","journal-title":"N Engl J Med."},{"key":"2803_CR33","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/gast.2002.37058","volume":"123","author":"CL Lai","year":"2002","unstructured":"Lai CL, Rosmawati M, Lao J, et al. Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. Gastroenterology. 2002;123:1831\u20138.","journal-title":"Gastroenterology."},{"key":"2803_CR34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/hep.22658","volume":"49","author":"N Leung","year":"2009","unstructured":"Leung N, Peng CY, Hann HW, et al. Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir. Hepatology. 2009;49:72\u20139.","journal-title":"Hepatology."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2803-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-012-2803-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2803-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T11:22:54Z","timestamp":1559647374000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-012-2803-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,18]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2803"],"URL":"https:\/\/doi.org\/10.1245\/s10434-012-2803-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,18]]}}}